Summary
- Current Price
- As of today, TECH price is $72.35, down -0.17% on
- Current Price All-Time High
- TECH price is currently -46.79% below its historical high of $135.96 set on
- Market Cap
- TECH current market cap is $11B, up +34.75% over the past 365 days
- PE Ratio
- TECH current PE ratio is 62.45
- Revenue
- TECH current annual revenue is $1.22B, down -0.38% year-over-year
- Next Earnings
- The next earnings release for TECH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Bio-Techne Corporation |
| Ticker | NASDAQ: TECH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bio-techne.com |
| Employees | 3,100 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $72.35 | |
| Price, 1D Change | -0.17% | |
| Market Cap | $11B | |
| TTM Dividend Yield | 0.44% | |
| PE Ratio | 62.45 | |
| Beta | 0.87 | |
| Revenue | $1.22B | |
| Revenue, 1Y Change | -0.38% | |
| EPS | $1.16 | |
| EPS, 1Y Change | +152.17% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.08 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $1.16 | |
| EPS Estimate | $1.71 | N/A |
| EPS Est. Change | +47.43% | N/A |
| Revenue | $1.22B | |
| Revenue Estimate | $1.39B | N/A |
| Revenue Est. Change | +14.48% | N/A |
| Current Price | $72.35 | |
| Price Target | $73.00 | - |
| Price Tgt. Change | +0.90% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.78 | $1.05 | -41.27% | |
| $1.91 | $0.46 | -75.92% | |
| $2.04 | $1.16 | -43.16% | |
| $1.71 | N/A | +47.43% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.16B | $1.16B | -0.02% | |
| $1.22B | $1.22B | +0.11% | |
| $1.21B | $1.22B | +0.45% | |
| $1.39B | N/A | +14.48% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +33.17% | |
| Price, 3Y | -7.55% | |
| Market Cap, 1Y | +34.75% | |
| Market Cap, 3Y | -8.03% | |
| Revenue, 1Y | -0.38% | |
| Revenue, 3Y | +6.89% | |
| EPS, 1Y | +152.17% | |
| EPS, 3Y | -34.27% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $72.35 | |
| SMA 200 | $60.69 | |
| SMA 50 | $70.60 | |
| EMA 200 | $61.99 | |
| EMA 50 | $69.03 | |
| MACD | $0.68 | |
| Beta | 0.87 | |
| ATR | $0.35 | |
| 14-Day RSI | 65.70 | |
| 10-Day Volatility | 3.03% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.08 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.44% | |
| Total Dividend | $0.32 | |
| $49.92M | ||
| 27.45% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $1.22B | |
| EPS | $1.16 | |
| Gross Profit | $799.07M | |
| Gross Margin | 65.77% | |
| Operating Income | $251.89M | |
| Operating Margin | 20.73% | |
| Net Income | $181.84M | |
| Net Margin | 14.97% | |
| EBITDA | $349.25M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.14 | |
| 4.55 | ||
| 3.35 | ||
| - | ||
| 7 | ||
| 15.91 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 62.45 | |
| 9.34 | ||
| 5.38 | ||
| 31.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $2.11B | |
| $264.71M | ||
| $2.59B | ||
| $744.40M | ||
| $478.51M | ||
| $163.70M | ||
| Total Debt | $289.09M | |
| $14.94M | ||
| $26.70M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.03B | ||
| $547.18M | ||
| $415.97M | ||
| $0.00 | ||
| $97.36M | ||
| $0.00 | ||
| $58.82M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $292.07M | ||
| -$18.19M | ||
| -$169.11M | ||
| Capex | $28.85M | |
| $263.22M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wells Fargo | → | |
| RBC Capital | → | |
| TD Cowen | → | |
| Benchmark | → | |
| Citigroup | → | |
| William Blair | → | |
| Stephens & Co. | → | |
| Baird | → | |
| Piper Sandler | ||
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
No data
Screeners with TECH
FAQ
- What is the ticker symbol for Bio-Techne Corporation?
- The ticker symbol for Bio-Techne Corporation is NASDAQ:TECH
- Does Bio-Techne Corporation pay dividends?
- Yes, Bio-Techne Corporation pays dividends. The last payment was $0.08, with an ex-dividend date on August 24, 2026
- What sector is Bio-Techne Corporation in?
- Bio-Techne Corporation is in the Healthcare sector
- What industry is Bio-Techne Corporation in?
- Bio-Techne Corporation is in the Biotechnology industry
- What country is Bio-Techne Corporation based in?
- Bio-Techne Corporation is headquartered in United States
- When did Bio-Techne Corporation go public?
- Bio-Techne Corporation initial public offering (IPO) was on February 9, 1989
- Is Bio-Techne Corporation in the S&P 500?
- Yes, Bio-Techne Corporation is included in the S&P 500 index
- Is Bio-Techne Corporation in the NASDAQ 100?
- No, Bio-Techne Corporation is not included in the NASDAQ 100 index
- Is Bio-Techne Corporation in the Dow Jones?
- No, Bio-Techne Corporation is not included in the Dow Jones index
- When was Bio-Techne Corporation last earnings report?
- Bio-Techne Corporation's most recent earnings report was on August 12, 2026
- When does Bio-Techne Corporation report earnings?
- The next expected earnings date for Bio-Techne Corporation is November 9, 2026
Data Sources & References
- TECH Official Website www.bio-techne.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- TECH Profile on Yahoo Finance finance.yahoo.com/quote/TECH
- TECH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tech